Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Biopharmaceutical Contract Manufacturings market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.2% during the forecast period.
This report presents the market size and development trends by detailing the Biopharmaceutical Contract Manufacturings market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Biopharmaceutical Contract Manufacturings market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Biopharmaceutical Contract Manufacturings industry and will help you to build a panoramic view of the industrial development.
Biopharmaceutical Contract Manufacturings Market, By Type:
Active Pharmaceutical Ingredient (API) Manufacturing
Finished Dosage Formulation (FDF) Development & Manufacturing
Others
Biopharmaceutical Contract Manufacturings Market, By Application:
Oncology
Central Nervous System
Cardiovascular Disorders
Infectious Diseases
Pulmonary Disorders
Metabolic Disorders
Others
Some of the leading players are as follows:
Abbvie Inc
Boehringer Ingelheim
Patheon Inc
Aenova
Famar.
Lonza.
Cambrex Corporation
Baxter Biopharma Solutions.
Pfizer Centresource
Catalent Inc
Recipharm AB.
Jubilant Life Sciences Ltd
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Biopharmaceutical Contract Manufacturings Market: Technology Type Analysis
-
4.1 Biopharmaceutical Contract Manufacturings Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Biopharmaceutical Contract Manufacturings Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Active Pharmaceutical Ingredient (API) Manufacturing
4.3.2 Finished Dosage Formulation (FDF) Development & Manufacturing
4.3.3 Others
5 Biopharmaceutical Contract Manufacturings Market: Product Analysis
-
5.1 Biopharmaceutical Contract Manufacturings Product Market Share Analysis, 2018 & 2026
-
5.2 Biopharmaceutical Contract Manufacturings Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Biopharmaceutical Contract Manufacturings Market: Application Analysis
-
6.1 Biopharmaceutical Contract Manufacturings Application Market Share Analysis, 2018 & 2026
-
6.2 Biopharmaceutical Contract Manufacturings Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Oncology
6.3.2 Central Nervous System
6.3.3 Cardiovascular Disorders
6.3.4 Infectious Diseases
6.3.5 Pulmonary Disorders
6.3.6 Metabolic Disorders
6.3.7 Others
7 Biopharmaceutical Contract Manufacturings Market: Regional Analysis
-
7.1 Biopharmaceutical Contract Manufacturings Regional Market Share Analysis, 2018 & 2026
-
7.2 Biopharmaceutical Contract Manufacturings Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Abbvie Inc
9.1.1 Abbvie Inc Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Boehringer Ingelheim
9.2.1 Boehringer Ingelheim Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Patheon Inc
9.3.1 Patheon Inc Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Aenova
9.4.1 Aenova Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Famar.
9.5.1 Famar. Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Lonza.
9.6.1 Lonza. Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Cambrex Corporation
9.7.1 Cambrex Corporation Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Baxter Biopharma Solutions.
9.8.1 Baxter Biopharma Solutions. Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Pfizer Centresource
9.9.1 Pfizer Centresource Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Catalent Inc
9.10.1 Catalent Inc Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Recipharm AB.
9.11.1 Recipharm AB. Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Jubilant Life Sciences Ltd
9.12.1 Jubilant Life Sciences Ltd Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
The List of Tables and Figures (Totals 84 Figures and 134 Tables)
Figure Active Pharmaceutical Ingredient (API) Manufacturing Biopharmaceutical Contract Manufacturings market, 2015 - 2026 (USD Million)
Figure Finished Dosage Formulation (FDF) Development & Manufacturing Biopharmaceutical Contract Manufacturings market, 2015 - 2026 (USD Million)
Figure Others Biopharmaceutical Contract Manufacturings market, 2015 - 2026 (USD Million)
Figure Oncology market, 2015 - 2026 (USD Million)
Figure Central Nervous System market, 2015 - 2026 (USD Million)
Figure Cardiovascular Disorders market, 2015 - 2026 (USD Million)
Figure Infectious Diseases market, 2015 - 2026 (USD Million)
Figure Pulmonary Disorders market, 2015 - 2026 (USD Million)
Figure Metabolic Disorders market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Biopharmaceutical Contract Manufacturings market, by country, 2015 - 2026 (USD Million)
-
Table North America Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table North America Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table North America Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table Canada Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table Canada Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Europe Biopharmaceutical Contract Manufacturings market, by country, 2015 - 2026 (USD Million)
-
Table Europe Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table Europe Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table Europe Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table Germany Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table Germany Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table France Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table France Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table Italy Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table Italy Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table Spain Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table Spain Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Biopharmaceutical Contract Manufacturings market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table China Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table China Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table Japan Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table Japan Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table India Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table India Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Biopharmaceutical Contract Manufacturings market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table MEA Biopharmaceutical Contract Manufacturings market, by country, 2015 - 2026 (USD Million)
-
Table MEA Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table MEA Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table MEA Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Biopharmaceutical Contract Manufacturings market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Biopharmaceutical Contract Manufacturings market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Biopharmaceutical Contract Manufacturings market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Abbvie Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Patheon Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aenova Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Famar. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Lonza. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cambrex Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Baxter Biopharma Solutions. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Centresource Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Catalent Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Recipharm AB. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Jubilant Life Sciences Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
